Home The Word Brain	My Amedeo FAQ Privacy About
	Hanzi Hunter Learning 500 Chinese characters in 30 days is possible. Abstract • About

Chronic Heart Failure

Free Subscription 02.03.2026 1 Circ Heart Fail 3 Circulation 6 Eur Heart J 6 Eur J Heart Fail 2 Heart 2 Int J Cardiol 1 J Cardiovasc Pharmacol 2 PLoS One

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

Circ Heart Fail

1. KHURSHID S, Friedman SF, Kany S, D'Souza V, et al
   Artificial Intelligence-Enabled ECG Analysis to Predict Incident Heart Failure.
   Circ Heart Fail. 2026 Feb 23:e013927. doi: 10.1161/CIRCHEARTFAILURE.125.013927.
   PubMed         Abstract available
   
   

   
   Circulation

2. XU Y, Huang T, Zhang Y, Ji D, et al
   Risk of Heart Failure Hospitalization for GLP-1 Receptor Agonists Versus DPP-4 Inhibitors or SGLT-2 Inhibitors in Patients With Type 2 Diabetes: A Target Trial Emulation.
   Circulation. 2026 Feb 24. doi: 10.1161/CIRCULATIONAHA.125.075157.
   PubMed         Abstract available
   
   
3. MALLOY CR, Cheeran D
   Inhibiting Fatty Acid Oxidation With a Mitotrope in Heart Failure With Preserved Ejection Fraction.
   Circulation. 2026;153:564-566.
   PubMed        
   
   
4. HUNDERTMARK MJ, Birkhoelzer SM, Portwood C, Siu AG, et al
   IMPROVE-DiCE, a 2-Part, Open-Label, Phase 2a Trial Evaluating the Safety and Effectiveness of Ninerafaxstat in Patients With Cardiometabolic Syndromes.
   Circulation. 2026;153:550-563.
   PubMed         Abstract available
   
   

   
   Eur Heart J

5. DE BOER RA, Abdellatif M, Bauersachs J, Roger VL, et al
   Heart failure in the elderly: epidemiology, mechanisms, and management.
   Eur Heart J. 2026 Feb 28:ehag110. doi: 10.1093.
   PubMed         Abstract available
   
   
6. PACKER M
   Causal role of adipose tissue-derived adipokines in the pathogenesis of heart failure with preserved ejection fraction: experimental demonstration as the basis for clinical targeting.
   Eur Heart J. 2026 Feb 27:ehag029. doi: 10.1093.
   PubMed        
   
   
7. LUND LH, Maggioni AP, Crespo-Leiro MG, Laroche C, et al
   Outcomes of heart failure with reduced, mildly reduced, or preserved ejection fraction: the ESC HF III registry.
   Eur Heart J. 2026 Feb 25:ehaf1074. doi: 10.1093/eurheartj/ehaf1074.
   PubMed         Abstract available
   
   
8. CREA F
   Heart failure and cardiomypathies: epidemiology and management.
   Eur Heart J. 2026;47:877-882.
   PubMed        
   
   
9. CHEN CW, Saeed D, Woo YJ
   Adult heart transplantation in the USA and Western Europe: state of the art review.
   Eur Heart J. 2025 Nov 10:ehaf880. doi: 10.1093.
   PubMed         Abstract available
   
   
10. CONNORS JM, Gustafsson F, Uriel N, Pagani FD, et al
    Withdrawal of aspirin in patients with left ventricular assist device treated with vitamin K antagonists: impact of anticoagulation quality in the randomized ARIES-HM3 trial.
    Eur Heart J. 2025 Nov 7:ehaf745. doi: 10.1093.
    PubMed         Abstract available
    
    

    
    Eur J Heart Fail

11. SPAGNOLIN M, Fazzini L, Giaccherini C, D'Elia E, et al
    Outcome trajectories in hospitalized heart failure with preserved ejection fraction: a machine learning cluster analysis.
    Eur J Heart Fail. 2026 Feb 10:xuag037. doi: 10.1093.
    PubMed         Abstract available
    
    
12. QI X, Wang J, Chen L
    Letter regarding the article "Clinical profiles and prognostic impact of residual intravascular and tissue congestion in acute heart failure".
    Eur J Heart Fail. 2026 Feb 26:xuag050. doi: 10.1093.
    PubMed        
    
    
13. CEELEN DCH, Voors AA, Ter Maaten JM
    Response to Letter regarding the article "Clinical profiles and prognostic impact of residual intravascular and tissue congestion in acute heart failure".
    Eur J Heart Fail. 2026 Feb 26:xuag014. doi: 10.1093.
    PubMed        
    
    
14. GREENE SJ, Butler J, Fonarow GC
    Beyond Quadruple Therapy for Heart Failure with Reduced Ejection Fraction: Where Do Additional Medical Therapies Fit?
    Eur J Heart Fail. 2026 Feb 26:xuag053. doi: 10.1093.
    PubMed        
    
    
15. HACIL A, Piccoli M, Antakly-Hanon Y, Guglieri M, et al
    Association of SGLT2 inhibitors and new-onset dementia in non-diabetic patients with heart failure.
    Eur J Heart Fail. 2026 Feb 10:xuag038. doi: 10.1093.
    PubMed         Abstract available
    
    
16. YE B, Xu Y, Hirashima F, LeWinter MM, et al
    Normal abundance of immune cells in left ventricular myocardium from patients with heart failure and preserved ejection fraction.
    Eur J Heart Fail. 2026 Feb 10:xuag041. doi: 10.1093.
    PubMed         Abstract available
    
    

    
    Heart

17. SINAN UY
    Guideline-directed medical therapy in older heart failure patients: survival gains, evidence gaps and the challenge of implementation.
    Heart. 2026 Feb 26:heartjnl-2026-327799. doi: 10.1136/heartjnl-2026-327799.
    PubMed        
    
    
18. SATO R, Schmidt C, von Haehling S
    Invisible threats, visible consequences: metabolomic footprints of air pollution on heart failure.
    Heart. 2026 Feb 27:heartjnl-2026-327798. doi: 10.1136/heartjnl-2026-327798.
    PubMed        
    
    

    
    Int J Cardiol

19. OZAKI Y, Uemura Y, Kondo T, Kazama S, et al
    Hemodynamic transitions in pulmonary artery pulsatility index and compliance in advanced heart failure.
    Int J Cardiol. 2026;451:134248.
    PubMed         Abstract available
    
    
20. HASHIBA M, Hansen MT, Helge JW, Nielsen SK, et al
    Determinants of changes in peak oxygen consumption in patients with new-onset heart failure.
    Int J Cardiol. 2026;451:134252.
    PubMed         Abstract available
    
    

    
    J Cardiovasc Pharmacol

21. SARTO G, Simeone B, Sbandi F, Valenti V, et al
    Magnitude of blood pressure reduction in response to levosimendan infusion independently predicts in-hospital mortality in patients with acute heart failure.
    J Cardiovasc Pharmacol. 2026 Feb 23. doi: 10.1097/FJC.0000000000001811.
    PubMed         Abstract available
    
    

    
    PLoS One

22. MENDONCA DOS SANTOS P, Pardo I, Borges Pereira de Almeida MC, Santana de Oliveira R, et al
    Association between hemoglobin/red blood cell distribution width ratio and acute kidney injury in sepsis and heart failure patients.
    PLoS One. 2026;21:e0331332.
    PubMed         Abstract available
    
    
23. HE L, Zhang D, Zhang S, Ren Z, et al
    Dapagliflozin mitigates myocardial inflammation and metabolic stress in heart failure through STAT1 inhibition: Evidence from multi-omics analyses and experimental exploration.
    PLoS One. 2026;21:e0343296.
    PubMed         Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Chronic Heart Failure is free of charge. Privacy / Datenschutzerklärung | Imprint / Impressum